Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30

Lydia Montes; Estelle Tredez; Clara Yzet; Caroline Delette; Denis Chatelain; Delphine Lebon; Mathurin Fumery; Jean‐Pierre Marolleau

doi:10.1002/ccr3.2721

Clinical Case Reports (Jun 2020)

Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30

Lydia Montes,
Estelle Tredez,
Clara Yzet,
Caroline Delette,
Denis Chatelain,
Delphine Lebon,
Mathurin Fumery,
Jean‐Pierre Marolleau

Affiliations

Lydia Montes: Hematology and Cell Transplant Department CHU Amiens Amiens France
Estelle Tredez: Histology Department CHU Amiens Amiens France
Clara Yzet: Gastro‐enterology and Hepatology Department CHU Amiens Amiens France
Caroline Delette: Hematology and Cell Transplant Department CHU Amiens Amiens France
Denis Chatelain: Histology Department CHU Amiens Amiens France
Delphine Lebon: Hematology and Cell Transplant Department CHU Amiens Amiens France
Mathurin Fumery: Gastro‐enterology and Hepatology Department CHU Amiens Amiens France
Jean‐Pierre Marolleau: Hematology and Cell Transplant Department CHU Amiens Amiens France

DOI: https://doi.org/10.1002/ccr3.2721
Journal volume & issue: Vol. 8, no. 6
pp. 958 – 961

Abstract

Read online

Abstract Epstein‐Barr virus‐related mucocutaneous ulcer lymphoma is a rare entity promoted by immunosuppression. It is less described in inflammatory bowel diseases, and mostly these are refractory diseases. CD30 acts to Epstein‐Barr virus (EBV) local proliferation and thus could be an interesting target. Brentuximab vedotin could become a new helpful tool.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords